A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis
Clinical trial NCT01782664 · COMPLETED
Trial details
- NCT number
- NCT01782664
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-03-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.